Data search


search
Exact
Search

Results for MligTC455_23094

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_23094 371 7.74 Mlig455_021969

Neo: -

Age: -

Region-enriched R3: 4.168/0.00000

Mlig455_021969 {REF} {Length: 4499} {TRANSSPLICED} {RNA1509_12504, RNA1509_30322} {RNA1310_3897, RNA1509_30322} {RNA1509_30322, RNA815_21452}

Cumulative graph for MligTC455_23094

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 -5.622 3.359 1.00000 1.00000
RegionR2 -0.938 3.359 0.93746 1.00000
RegionR3 4.168 3.359 0.00000 0.00000
RegionR4 1.888 3.359 0.03999 0.16554
RegionR5 1.722 3.359 0.06713 0.23109
RegionR6 1.589 3.359 0.13457 0.65878
RegionR7 1.226 3.359 0.37064 1.00000
RegionR8 -4.033 3.359 0.99987 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 8.613 3.359 0.00797 0.41294
RegenerationR2 2.277 3.359 0.00963 0.15726
RegenerationR3 0.336 3.359 0.48538 0.85312
RegenerationR4 1.129 3.359 0.03141 0.28604
RegenerationR5 1.075 3.359 0.03451 0.30897
RegenerationR6 0.769 3.359 0.21365 0.55730
RegenerationBL -0.19 3.359 0.82783 1.00000
RegenerationTP 3.34 3.359 0.05056 0.36875


Genes with expression patterns similar to MligTC455_23094

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_23094 371 7.74 Mlig455_021969

Neo: -

Age: -

Region-enriched R3: 4.168/0.00000

6 1.000 1.000 1.000 1.000 1.000 1.000 Mlig455_021969 {REF} {Length: 4499} {TRANSSPLICED} {RNA1509_12504, RNA1509_30322} {RNA1310_3897, RNA1509_30322} {RNA1509_30322, RNA815_21452}
2. MligTC455_23093 345 7.19 Mlig455_021893

Neo: -

Age: Down-Up-Up

Region-enriched R3: 3.624/0.00000

4.58 0.835 0.943 0.940 0.961 0.901 - Mlig455_021893 {REF} {Length: 1735} {RNA1509_30322, RNA1509_50391} {RNA1310_32503, RNA1509_50391} {RNA1509_50391, RNA815_39630}
3. MligTC455_33254 462 9.62 Mlig455_055163

Neo: -

Age: logFC(26M/2M)=0.785

Region-enriched R3: 4.000/0.00000
Region-enriched R4: 2.682/0.00952

VCAN 3.445 0.866 0.824 - 0.950 0.805 - Mlig455_055163 {REF} {Length: 2071} {Pfam: Lectin C-type domain [PF00059.23, score=67.8]; UL45 protein, carbohydrate-binding C-type lectin-like [PF05473.14, score=27.6]} {Human: ENSG00000038427, VCAN, versican, [Score=54.3, Expect=7e-07]; ENSG00000152672, CLEC4F, C-type lectin domain family 4 member F, [Score=53.1, Expect=1e-06]} {Mouse: ENSMUSG00000021614, Vcan, versican, [Score=55.1, Expect=3e-07]} {Celegans: WBGene00020191, clec-53, C-type LECtin, [Score=62.4, Expect=2e-10]} {Smed: dd_Smed_v6_1489_0_1, dd_Smed_v6_1489_0_1, [Score=51.2, Expect=1e-06]} {RNA1509_25541} {RNA1310_14728} {RNA815_4830.2}
4. MligTC455_33253 470 9.79 Mlig455_006829

Neo: -

Age: Up-Down-Up, logFC(26M/2M)=0.763

Region-enriched R3: 3.956/0.00000
Region-enriched R4: 2.765/0.00326

3.44 0.872 0.814 - 0.952 0.802 - Mlig455_006829 {REF} {Length: 2010} {Pfam: Lectin C-type domain [PF00059.23, score=70.0]; UL45 protein, carbohydrate-binding C-type lectin-like [PF05473.14, score=22.2]} {Celegans: WBGene00020191, clec-53, C-type LECtin, [Score=61.2, Expect=6e-10]} {Smed: dd_Smed_v6_1489_0_1, dd_Smed_v6_1489_0_1, [Score=47.8, Expect=1e-05]} {RNA1509_25541} {RNA1310_14728} {RNA815_4830.2}
5. MligTC455_47182 14582 303.8 Mlig455_058015, Mlig455_058180, Mlig455_058206

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.558

Region-enriched R3: 3.886/0.00000
Region-enriched R4: 2.020/0.01181

GM2A 3.354 0.914 0.712 - 0.956 0.772 -

Mlig455_058015 {REF} {Length: 1913} {Pfam: ML domain [PF02221.17, score=41.0]} {Human: ENSG00000196743, GM2A, GM2 ganglioside activator, [Score=52.0, Expect=4e-08]} {Mouse: ENSMUSG00000000594, Gm2a, GM2 ganglioside activator protein, [Score=53.9, Expect=6e-09]} {Smed: dd_Smed_v6_214_1_1, dd_Smed_v6_214_1_1, [Score=73.9, Expect=6e-17]} {RNA1509_4247} {RNA1310_43150} {RNA815_23642.1}

Mlig455_058180 {REF} {Length: 1416} {Pfam: ML domain [PF02221.17, score=41.0]} {Human: ENSG00000196743, GM2A, GM2 ganglioside activator, [Score=52.0, Expect=4e-08]} {Mouse: ENSMUSG00000000594, Gm2a, GM2 ganglioside activator protein, [Score=53.9, Expect=6e-09]} {Smed: dd_Smed_v6_214_1_1, dd_Smed_v6_214_1_1, [Score=73.9, Expect=6e-17]} {RNA1509_4247} {RNA1310_43150} {RNA815_23642.1}

Mlig455_058206 {REF} {Length: 1589} {Pfam: ML domain [PF02221.17, score=41.0]} {Human: ENSG00000196743, GM2A, GM2 ganglioside activator, [Score=52.0, Expect=4e-08]} {Mouse: ENSMUSG00000000594, Gm2a, GM2 ganglioside activator protein, [Score=53.9, Expect=6e-09]} {Smed: dd_Smed_v6_214_1_1, dd_Smed_v6_214_1_1, [Score=73.9, Expect=6e-17]} {RNA1509_3837, RNA1509_4247, RNA1509_4841, RNA1509_5347} {RNA1310_43150, RNA1509_3837, RNA1509_4247, RNA1509_4841, RNA1509_5347} {RNA1509_3837, RNA1509_4247, RNA1509_4841, RNA1509_5347, RNA815_23642.1}
6. MligTC455_27242 14489 301.86 Mlig455_056957

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.849

Region-enriched R3: 2.848/0.00000
Region-enriched R5: 1.349/0.04924

GM2A 3.294 0.818 0.765 - 0.761 0.950 - Mlig455_056957 {REF} {Length: 877} {Pfam: ML domain [PF02221.17, score=41.0]} {Human: ENSG00000196743, GM2A, GM2 ganglioside activator, [Score=51.6, Expect=7e-08]} {Mouse: ENSMUSG00000000594, Gm2a, GM2 ganglioside activator protein, [Score=50.8, Expect=1e-07]} {Smed: dd_Smed_v6_214_1_1, dd_Smed_v6_214_1_1, [Score=56.2, Expect=3e-10]} {RNA1509_960} {RNA1310_28835.1} {RNA815_6681.1}
7. MligTC455_43194 11396 237.42 Mlig455_009763, Mlig455_070122

Neo: -

Age: Down-Down-Up

Region-enriched R3: 2.399/0.00716

CST3 2.678 0.862 - - 0.952 0.864 -

Mlig455_009763 {REF} {Length: 720} {Pfam: Cystatin domain [PF00031.23, score=28.8]} {Human: ENSG00000101439, CST3, cystatin C, [RH, Score=44.7, Expect=6e-06]} {RNA1509_26463, RNA1509_2883, RNA1509_6502} {RNA1310_51190, RNA1509_2883, RNA1509_6502} {RNA1509_2883, RNA1509_6502, RNA815_25269}

Mlig455_070122 {REF} {Length: 736} {Pfam: Cystatin domain [PF00031.23, score=28.8]} {Human: ENSG00000101439, CST3, cystatin C, [RH, Score=44.7, Expect=6e-06]} {RNA1509_26463, RNA1509_4516, RNA1509_5046, RNA1509_7022} {RNA1310_51190, RNA1509_26463, RNA1509_4516, RNA1509_5046, RNA1509_7022} {RNA1509_26463, RNA1509_4516, RNA1509_5046, RNA1509_7022, RNA815_25269}
8. MligTC455_18468 49 1.02 Mlig455_014453

Neo: -

Age: -

Region-enriched R4: 3.552/0.03158

2.661 0.744 - - 0.956 0.961 - Mlig455_014453 {REF} {Length: 1446} {Pfam: Lipase (class 3) [PF01764.27, score=96.6]} {Celegans: WBGene00022457, Y110A7A.7, [Score=158, Expect=6e-45]} {RNA1509_36256} {RNA1310_22408} {RNA815_9975}
9. MligTC455_46997 1302 27.12 Mlig455_018324

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=2.900

Region-enriched R4: 3.072/0.00026
Region-enriched R3: 2.531/0.00058
Region-enriched R5: 1.786/0.01855

CPA2 2.631 0.786 - - 0.892 0.953 - Mlig455_018324 {REF} {Length: 1747} {Pfam: Zinc carboxypeptidase [PF00246.26, score=269.1]; Carboxypeptidase activation peptide [PF02244.18, score=54.2]} {Human: ENSG00000158516, CPA2, carboxypeptidase A2, [RH, Score=287, Expect=3e-93]} {Mouse: ENSMUSG00000071553, Cpa2, carboxypeptidase A2, pancreatic, [RH, Score=288, Expect=2e-93]} {Dmel: FBgn0029807, CG3108, [RH, Score=266, Expect=8e-80]} {Celegans: WBGene00008521, F02D8.4, [RH, Score=251, Expect=3e-79]} {Smed: dd_Smed_v6_5999_0_1, dd_Smed_v6_5999_0_1, [RH, Score=254, Expect=1e-80]} {RNA1509_11873, RNA1509_20365} {RNA1310_21434, RNA1509_11873, RNA1509_20365} {RNA1509_11873, RNA1509_20365, RNA815_8679}
10. MligTC455_11766 201 4.18 Mlig455_048732

Neo: -

Age: -

Region-enriched R3: 3.689/0.00006

2.525 0.779 - - 0.787 0.959 - Mlig455_048732 {REF} {Length: 376} {NoTransDecoderORF} {RNA1310_75754} {RNA815_50709.2}
11. MligTC455_36083 1788 37.26 Mlig455_050276

Neo: -

Age: Down-Down-Up

Region-enriched R3: 2.753/0.00000
Region-enriched R4: 2.492/0.00000
Region-enriched R5: 1.839/0.00004

2.505 0.819 0.729 - 0.957 - - Mlig455_050276 {REF} {Length: 2874} {Pfam: Transforming growth factor beta like domain [PF00019.22, score=19.6]} {RNA1509_5434} {RNA1310_5336} {RNA815_1739.1}
12. MligTC455_52856 135 2.82 Mlig455_040428

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=2.836

Region-enriched R3: 4.616/0.00003
Region-enriched R4: 3.783/0.00184
Region-enriched R5: 3.508/0.00227

MCFD2 1.853 0.896 - - 0.957 - - Mlig455_040428 {REF} {Length: 998} {Pfam: EF-hand domain pair [PF13499.8, score=45.6]; EF-hand domain [PF13405.8, score=36.2]; EF hand [PF00036.34, score=36.1]; EF-hand domain pair [PF13833.8, score=25.7]} {Human: ENSG00000180398, MCFD2, multiple coagulation factor deficiency 2, [Score=62.0, Expect=5e-12]} {Mouse: ENSMUSG00000024150, Mcfd2, multiple coagulation factor deficiency 2, [Score=60.1, Expect=2e-11]} {Dmel: FBgn0037798, CG12817, [RH, Score=53.5, Expect=6e-09]} {Celegans: WBGene00010075, F55A11.1, [RH, Score=70.1, Expect=3e-15]} {RNA1509_28625} {RNA1310_37099} {RNA815_18915}
13. MligTC455_38555 1592 33.16 Mlig455_042871, Mlig455_042872, Mlig455_042880

Neo: -

Age: Down-Up-Down

Region-enriched R3: 3.619/0.00000

AMY1B, AMY1C, AMY2B 1.841 0.873 - - 0.968 - -

Mlig455_042871 {REF} {Length: 656} {Human: ENSG00000240038, AMY2B, amylase, alpha 2B (pancreatic), [Score=136, Expect=1e-38]; ENSG00000243480, AMY2A, amylase, alpha 2A (pancreatic), [Score=135, Expect=5e-40]; ENSG00000174876, AMY1B, amylase, alpha 1B (salivary), [Score=133, Expect=6e-39]; ENSG00000237763, AMY1A, amylase, alpha 1A (salivary), [Score=133, Expect=6e-39]; ENSG00000187733, AMY1C, amylase, alpha 1C (salivary), [Score=132, Expect=2e-36]} {Mouse: ENSMUSG00000074264, Amy1, amylase 1, salivary, [Score=131, Expect=6e-38]; ENSMUSG00000070360, Amy2a1, amylase 2a1, [Score=125, Expect=8e-36]} {Dmel: FBgn0020506, Amyrel, [Score=122, Expect=6e-33]} {Celegans: WBGene00008220, C50B6.7, Alpha-amylase, [Score=106, Expect=4e-27]} {RNA1509_1421} {RNA1310_11165} {RNA815_3708.1}

Mlig455_042872 {REF} {Length: 1146} {Pfam: Alpha amylase, C-terminal all-beta domain [PF02806.20, score=43.6]} {Human: ENSG00000174876, AMY1B, amylase, alpha 1B (salivary), [Score=315, Expect=1e-104]; ENSG00000237763, AMY1A, amylase, alpha 1A (salivary), [Score=315, Expect=1e-104]; ENSG00000187733, AMY1C, amylase, alpha 1C (salivary), [Score=315, Expect=1e-104]; ENSG00000240038, AMY2B, amylase, alpha 2B (pancreatic), [Score=312, Expect=3e-103]; ENSG00000243480, AMY2A, amylase, alpha 2A (pancreatic), [Score=312, Expect=2e-103]} {Mouse: ENSMUSG00000096569, Amy2a2, amylase 2a2, [Score=317, Expect=3e-105]; ENSMUSG00000096770, Amy2a4, amylase 2a4, [Score=317, Expect=3e-105]; ENSMUSG00000093931, Amy2a3, amylase 2a3, [Score=317, Expect=3e-105]; ENSMUSG00000074268, Amy2a5, amylase 2a5, [Score=317, Expect=3e-105]; ENSMUSG00000074264, Amy1, amylase 1, salivary, [Score=310, Expect=1e-102]} {Dmel: FBgn0000078, Amy-d, Amylase distal, [Score=269, Expect=7e-87]} {Celegans: WBGene00008220, C50B6.7, Alpha-amylase, [Score=154, Expect=4e-42]} {RNA1509_1421} {RNA1310_7529} {RNA815_3708.1}

Mlig455_042880 {REF} {Length: 1770} {Pfam: Alpha amylase, catalytic domain [PF00128.26, score=56.3]; Alpha amylase, C-terminal all-beta domain [PF02806.20, score=42.2]} {Human: ENSG00000187733, AMY1C, amylase, alpha 1C (salivary), [RH, Score=588, Expect=0.0]; ENSG00000174876, AMY1B, amylase, alpha 1B (salivary), [RH, Score=588, Expect=0.0]; ENSG00000237763, AMY1A, amylase, alpha 1A (salivary), [RH, Score=588, Expect=0.0]; ENSG00000240038, AMY2B, amylase, alpha 2B (pancreatic), [RH, Score=587, Expect=0.0]; ENSG00000243480, AMY2A, amylase, alpha 2A (pancreatic), [RH, Score=585, Expect=0.0]} {Mouse: ENSMUSG00000074264, Amy1, amylase 1, salivary, [RH, Score=580, Expect=0.0]; ENSMUSG00000096770, Amy2a4, amylase 2a4, [RH, Score=570, Expect=0.0]; ENSMUSG00000074268, Amy2a5, amylase 2a5, [RH, Score=570, Expect=0.0]; ENSMUSG00000093931, Amy2a3, amylase 2a3, [RH, Score=570, Expect=0.0]; ENSMUSG00000096569, Amy2a2, amylase 2a2, [RH, Score=570, Expect=0.0]} {Dmel: FBgn0000078, Amy-d, Amylase distal, [RH, Score=492, Expect=4e-171]} {Celegans: WBGene00008220, C50B6.7, Alpha-amylase, [Score=358, Expect=6e-116]} {RNA1509_1421} {RNA1310_7529} {RNA815_3708.1}
14. MligTC455_16020 273 5.69 Mlig455_052333

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.890

Region-enriched R3: 4.114/0.00000

1.84 - - - 0.889 0.951 - Mlig455_052333 {REF} {Length: 1687} {Pfam: RING-type zinc-finger [PF13445.8, score=22.8]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=20.2]} {RNA1509_36870} {RNA1310_20406} {RNA815_6394}
15. MligTC455_42922 1184 24.67 Mlig455_026345

Neo: -

Age: logFC(26M/2M)=0.973

Region-enriched R3: 3.300/0.00000
Region-enriched R4: 1.908/0.02891

1.839 0.861 - - 0.978 - - Mlig455_026345 {REF} {Length: 2368} {Pfam: Group 7 allergen [PF16984.7, score=52.6]} {RNA1509_14255} {RNA1310_17894, RNA1509_14255} {RNA1509_14255, RNA815_9024}
16. MligTC455_38556 168 3.5 Mlig455_049546

Neo: -

Age: logFC(26M/2M)=-0.547

Region-enriched R3: 4.481/0.00055

AMY1C 1.789 0.834 - - 0.955 - - Mlig455_049546 {REF} {Length: 2273} {Pfam: Alpha amylase, catalytic domain [PF00128.26, score=54.2]; Alpha amylase, C-terminal all-beta domain [PF02806.20, score=41.8]} {Human: ENSG00000187733, AMY1C, amylase, alpha 1C (salivary), [RH, Score=592, Expect=0.0]; ENSG00000237763, AMY1A, amylase, alpha 1A (salivary), [RH, Score=592, Expect=0.0]; ENSG00000174876, AMY1B, amylase, alpha 1B (salivary), [RH, Score=592, Expect=0.0]; ENSG00000240038, AMY2B, amylase, alpha 2B (pancreatic), [RH, Score=591, Expect=0.0]; ENSG00000243480, AMY2A, amylase, alpha 2A (pancreatic), [RH, Score=588, Expect=0.0]} {Mouse: ENSMUSG00000074264, Amy1, amylase 1, salivary, [RH, Score=584, Expect=0.0]; ENSMUSG00000096770, Amy2a4, amylase 2a4, [RH, Score=575, Expect=0.0]; ENSMUSG00000096569, Amy2a2, amylase 2a2, [RH, Score=575, Expect=0.0]; ENSMUSG00000093931, Amy2a3, amylase 2a3, [RH, Score=575, Expect=0.0]; ENSMUSG00000074268, Amy2a5, amylase 2a5, [RH, Score=575, Expect=0.0]} {Dmel: FBgn0000078, Amy-d, Amylase distal, [RH, Score=492, Expect=5e-171]} {Celegans: WBGene00008220, C50B6.7, Alpha-amylase, [Score=359, Expect=2e-116]} {RNA1509_1421} {RNA1310_11165, RNA1509_1421} {RNA1509_1421, RNA815_3708.1}
17. MligTC455_18466 2786 58.04 Mlig455_005607

Neo: -

Age: logFC(26M/2M)=0.391

Region-enriched R3: 1.999/0.00016
Region-enriched R4: 1.673/0.00718
Region-enriched R5: 1.508/0.00283

1.72 0.755 - - - 0.965 - Mlig455_005607 {REF} {Length: 1941} {Pfam: Lipase (class 3) [PF01764.27, score=94.6]} {Celegans: WBGene00022457, Y110A7A.7, [Score=154, Expect=9e-44]} {RNA1509_36256, RNA1509_4777, RNA1509_8532} {RNA1310_22408, RNA1509_36256, RNA1509_4777, RNA1509_8532} {RNA1509_36256, RNA1509_4777, RNA1509_8532, RNA815_9975}
18. MligTC455_24537 46 0.96 Mlig455_009280

Neo: -

Age: logFC(26M/2M)=1.720

Region-enriched R4: 3.726/0.04899
Region-enriched R3: 3.461/0.04295

P4HB 1.687 0.725 - - 0.962 - - Mlig455_009280 {REF} {Length: 2535} {Pfam: Thioredoxin [PF00085.22, score=151.6]; Thioredoxin-like domain [PF13848.8, score=137.0]; Thioredoxin-like [PF13905.8, score=36.7]; Calsequestrin [PF01216.19, score=30.9]; ERp29, N-terminal domain [PF07912.15, score=29.5]; Thioredoxin-like [PF13899.8, score=27.9]; Thioredoxin-like domain [PF13098.8, score=27.8]; OST3 / OST6 family, transporter family [PF04756.15, score=26.5]; AhpC/TSA family [PF00578.23, score=19.0]} {Human: ENSG00000185624, P4HB, prolyl 4-hydroxylase subunit beta, [Score=416, Expect=4e-140]} {Mouse: ENSMUSG00000025130, P4hb, prolyl 4-hydroxylase, beta polypeptide, [Score=416, Expect=5e-140]} {Dmel: FBgn0014002, Pdi, Protein disulfide isomerase, [Score=381, Expect=4e-127]} {Celegans: WBGene00003963, pdi-2, Protein disulfide-isomerase 2, [Score=402, Expect=3e-135]} {Smed: dd_Smed_v6_250_0_1, dd_Smed_v6_250_0_1, [Score=419, Expect=4e-142]} {RNA1509_26478} {RNA1310_9678, RNA1509_26478} {RNA1509_26478, RNA815_5042}
19. MligTC455_12593 435 9.05 Mlig455_001017, Mlig455_064255

Neo: Irradiation

Age: -

Region-specific R5: 4.552

Region-enriched R5: 3.735/0.00000

OVCH1, TMPRSS7 0.962 - - - 0.962 - -

Mlig455_001017 {REF} {Length: 2588} {Pfam: CUB domain [PF00431.22, score=66.2]; Low-density lipoprotein receptor domain class A [PF00057.20, score=62.9]; Trypsin [PF00089.28, score=26.2]} {Human: ENSG00000176040, TMPRSS7, transmembrane serine protease 7, [Score=86.7, Expect=3e-18]; ENSG00000187045, TMPRSS6, transmembrane serine protease 6, [Score=82.4, Expect=7e-17]} {Mouse: ENSMUSG00000033177, Tmprss7, transmembrane serine protease 7, [Score=88.6, Expect=5e-19]; ENSMUSG00000031995, St14, suppression of tumorigenicity 14 (colon carcinoma), [Score=84.3, Expect=1e-17]} {Dmel: FBgn0066101, LpR1, Lipophorin receptor 1, [Score=73.2, Expect=5e-14]} {Celegans: WBGene00020481, T13C2.6, [Score=73.9, Expect=2e-14]} {Smed: dd_Smed_v6_9829_0_1, dd_Smed_v6_9829_0_1, [Score=58.9, Expect=1e-09]} {RNA1509_47790} {RNA1310_12212.1} {RNA815_13365}

Mlig455_064255 {REF} {Length: 2400} {Pfam: Trypsin [PF00089.28, score=246.4]; Low-density lipoprotein receptor domain class A [PF00057.20, score=65.2]; CUB domain [PF00431.22, score=65.1]; Trypsin-like peptidase domain [PF13365.8, score=29.0]; Domain of unknown function (DUF1986) [PF09342.13, score=24.6]} {Human: ENSG00000187950, OVCH1, ovochymase 1, [RH, Score=209, Expect=5e-58]} {Mouse: ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [RH, Score=224, Expect=2e-64]} {Dmel: FBgn0042098, CG18735, [RH, Score=185, Expect=1e-53]} {Celegans: WBGene00006619, try-1, TRYpsin-like protease, [RH, Score=165, Expect=6e-47]} {Smed: dd_Smed_v6_790_0_1, dd_Smed_v6_790_0_1, [Score=179, Expect=3e-48]} {RNA1509_27528, RNA1509_57567} {RNA1310_12212.1, RNA1509_27528, RNA1509_57567} {RNA1509_27528, RNA1509_57567, RNA815_13365}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA